In8bio, Inc. 8-K Filing
Ticker: INAB · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | 8-K |
| Filed Date | Nov 24, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by In8bio, Inc. (ticker: INAB) to the SEC on Nov 24, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (nge on which registered Common Stock, $0.0001 par value per share INAB The Nasdaq).
How long is this filing?
In8bio, Inc.'s 8-K filing is 2 pages with approximately 559 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-11-24 08:00:10
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share INAB The Nasdaq
Filing Documents
- d11812d8k.htm (8-K) — 25KB
- 0001193125-25-292057.txt ( ) — 140KB
- inab-20251121.xsd (EX-101.SCH) — 3KB
- inab-20251121_lab.xml (EX-101.LAB) — 18KB
- inab-20251121_pre.xml (EX-101.PRE) — 11KB
- d11812d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. IN8bio, Inc. Date: November 24, 2025 By: /s/ Patrick McCall Patrick McCall Chief Financial Officer and Secretary (Principal Financial and Accounting Officer)